primary care & preventionformula

ASCVD Pooled Cohort Equations (2013 ACC/AHA)

The Pooled Cohort Equations estimate the 10-year risk of a first atherosclerotic cardiovascular event (MI or stroke) in adults aged 40–79 without prior ASCVD. Used to guide statin therapy and preventive intensity per ACC/AHA guidelines.

inputs

years
PCE uses race-specific coefficients
mg/dL
mg/dL
mmHg

✓ when to use

Use in adults aged 40–79 without known ASCVD, diabetes (some guidelines calculate risk for diabetics separately), or very high LDL (≥190 mg/dL, who warrant statins regardless) to guide primary prevention statin decisions. The 2018 ACC/AHA Cholesterol Guideline uses PCE thresholds to guide statin intensity.

✗ when not to use

Not for patients with established ASCVD (secondary prevention — they need statins regardless). Not validated outside the 40–79 age range. The PCE includes race as a variable (Black vs White/Other), which has been debated. The equations may overestimate risk in some populations (European, East Asian) and underestimate in others (South Asian). For UK patients, QRISK3 is the recommended tool. For European patients, SCORE2 is preferred.

clinical pearls

  • The PCE is the US standard. In the UK, use QRISK3. In Europe, use SCORE2. These tools use different populations, variables, and endpoints — they are not interchangeable.
  • The PCE may overestimate risk in low-risk populations (e.g., middle-class white Americans, East Asians) and underestimate in high-risk groups (South Asians). If the predicted risk seems discordant with clinical impression, consider CAC scoring for reclassification.
  • The 7.5% threshold triggers a statin recommendation, but this should be a shared decision. Use the risk estimate as a conversation starter, not an automatic prescription.
  • Risk-enhancing factors (family history of premature ASCVD, LDL ≥160, hs-CRP ≥2, ABI <0.9, South Asian ancestry, metabolic syndrome) can tip the decision toward statin therapy at borderline or intermediate risk levels.
  • Coronary artery calcium (CAC) scoring is the most powerful reclassification tool for intermediate-risk patients. CAC = 0 suggests lower risk and may allow deferral of statin therapy. CAC ≥100 (or ≥75th percentile) strongly supports statin initiation.

related tools

qrisk3UK-recommended CVD risk toolscore2European CVD risk toolbmiWeight management in CVD prevention